| Code | Description | Claims | Beneficiaries | Total Paid |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,143 |
4,644 |
$45K |
| 87507 |
|
1,379 |
1,295 |
$18K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
838 |
755 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
165 |
164 |
$7K |
| 87486 |
|
1,843 |
1,715 |
$4K |
| 87581 |
|
1,843 |
1,715 |
$4K |
| 87631 |
|
1,146 |
1,136 |
$3K |
| 87632 |
|
89 |
89 |
$3K |
| 87186 |
|
121 |
89 |
$2K |
| 87541 |
|
984 |
949 |
$2K |
| 87150 |
|
966 |
959 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
70 |
70 |
$1K |
| 86003 |
|
95 |
93 |
$1K |
| 86008 |
|
148 |
148 |
$956.36 |
| 87500 |
|
1,497 |
1,485 |
$816.07 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
189 |
175 |
$757.66 |
| 87641 |
|
3,048 |
2,986 |
$739.24 |
| 87481 |
|
1,721 |
1,696 |
$728.20 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
123 |
122 |
$675.00 |
| 87640 |
|
1,446 |
1,428 |
$627.21 |
| 87652 |
|
490 |
482 |
$610.80 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
493 |
459 |
$563.74 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28 |
26 |
$468.27 |
| 87634 |
|
219 |
217 |
$449.28 |
| 80061 |
Lipid panel |
56 |
53 |
$415.20 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
449 |
447 |
$342.50 |
| 80053 |
Comprehensive metabolic panel |
58 |
55 |
$308.22 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
218 |
216 |
$306.56 |
| 87529 |
|
228 |
225 |
$273.69 |
| 99000 |
|
114 |
109 |
$272.50 |
| 87505 |
|
55 |
54 |
$228.08 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48 |
46 |
$209.09 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
75 |
74 |
$200.00 |
| 87653 |
|
1,091 |
1,087 |
$180.56 |
| 87498 |
|
220 |
218 |
$171.26 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
123 |
117 |
$105.68 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$85.34 |
| 82785 |
|
183 |
181 |
$78.84 |
| 87482 |
|
87 |
87 |
$44.59 |
| 99072 |
|
25 |
25 |
$24.16 |
| 87101 |
|
373 |
371 |
$0.00 |